Suppr超能文献

未服用抗精神病药物的老年精神分裂症患者纹状体中多巴胺D₂/₃受体可用性的[¹¹C]雷氯必利PET研究

Dopamine D₂/₃ receptor availability in the striatum of antipsychotic-free older patients with schizophrenia-A [¹¹C]-raclopride PET study.

作者信息

Nakajima Shinichiro, Caravaggio Fernando, Mamo David C, Mulsant Benoit H, Chung Jun Ku, Plitman Eric, Iwata Yusuke, Gerretsen Philip, Uchida Hiroyuki, Suzuki Takefumi, Mar Wanna, Wilson Alan A, Houle Sylvain, Graff-Guerrero Ariel

机构信息

Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, Canada; Geriatric Mental Health Division, Centre for Addiction and Mental Health, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada; Department of Neuropsychiatry, School of Medicine, Keio University, Tokyo, Japan.

Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, Canada; Institute of Medical Science, University of Toronto, Toronto, Canada.

出版信息

Schizophr Res. 2015 May;164(1-3):263-7. doi: 10.1016/j.schres.2015.02.020. Epub 2015 Mar 8.

Abstract

BACKGROUND

No study has examined dopamine D₂/₃ receptor (D₂/₃R) availability in antipsychotic-free older patients with schizophrenia.

METHODS

We included patients with schizophrenia 50 years or older who were antipsychotic-free for at least 3 months. We compared non-displaceable binding potential (BPND) of [(11)C]-raclopride in the caudate, putamen, ventral striatum, and globus pallidus between patients and age- and sex-matched healthy controls.

RESULTS

Ten patients participated (antipsychotic-naive=4). No differences in BPND were found between patients and controls in any ROIs (F(1, 72)=.42, p=.52).

CONCLUSION

The preliminary results suggest no differences in D₂/₃R availability between antipsychotic-free older patients with schizophrenia and controls.

摘要

背景

尚无研究考察未服用抗精神病药物的老年精神分裂症患者的多巴胺D₂/₃受体(D₂/₃R)可用性。

方法

我们纳入了年龄在50岁及以上、至少3个月未服用抗精神病药物的精神分裂症患者。我们比较了患者与年龄和性别匹配的健康对照者在尾状核、壳核、腹侧纹状体和苍白球中[(11)C] - 雷氯必利的非置换性结合潜能(BPND)。

结果

10名患者参与研究(初发未服抗精神病药物者 = 4名)。在任何感兴趣区域(ROI)中,患者与对照者之间的BPND均未发现差异(F(1, 72)=.42,p =.52)。

结论

初步结果表明,未服用抗精神病药物的老年精神分裂症患者与对照者之间的D₂/₃R可用性无差异。

相似文献

2
Dopamine D2 receptor binding in drug-naïve patients with schizophrenia examined with raclopride-C11 and positron emission tomography.
Psychiatry Res. 2006 Dec 1;148(2-3):165-73. doi: 10.1016/j.pscychresns.2006.05.009. Epub 2006 Nov 13.
4
Affinity States of Striatal Dopamine D2 Receptors in Antipsychotic-Free Patients with Schizophrenia.
Int J Neuropsychopharmacol. 2017 Nov 1;20(11):928-935. doi: 10.1093/ijnp/pyx063.
6
Increased synaptic dopamine function in associative regions of the striatum in schizophrenia.
Arch Gen Psychiatry. 2010 Mar;67(3):231-9. doi: 10.1001/archgenpsychiatry.2010.10.
7
Cognition and Dopamine D Receptor Availability in the Striatum in Older Patients with Schizophrenia.
Am J Geriatr Psychiatry. 2017 Jan;25(1):1-10. doi: 10.1016/j.jagp.2016.08.001. Epub 2016 Aug 2.
8
Theta burst stimulation in the negative symptoms of schizophrenia and striatal dopamine release. An iTBS-[11C]raclopride PET case study.
Schizophr Res. 2011 Sep;131(1-3):264-5. doi: 10.1016/j.schres.2011.05.019. Epub 2011 Jun 12.
10

引用本文的文献

1
Epigenetic Alterations Impact on Antipsychotic Treatment in Elderly Patients.
Curr Treat Options Psychiatry. 2018 Mar;5(1):17-29. Epub 2018 Jan 15.
2
Amotivation is associated with smaller ventral striatum volumes in older patients with schizophrenia.
Int J Geriatr Psychiatry. 2018 Mar;33(3):523-530. doi: 10.1002/gps.4818. Epub 2017 Nov 7.
3
Systemic inflammation enhances stimulant-induced striatal dopamine elevation.
Transl Psychiatry. 2017 Mar 28;7(3):e1076. doi: 10.1038/tp.2017.18.
4

本文引用的文献

2
Treating older adults with schizophrenia: challenges and opportunities.
Schizophr Bull. 2013 Sep;39(5):966-8. doi: 10.1093/schbul/sbt043. Epub 2013 Apr 3.
3
The nature of dopamine dysfunction in schizophrenia and what this means for treatment.
Arch Gen Psychiatry. 2012 Aug;69(8):776-86. doi: 10.1001/archgenpsychiatry.2012.169.
4
Divergent trajectories of physical, cognitive, and psychosocial aging in schizophrenia.
Schizophr Bull. 2011 May;37(3):451-5. doi: 10.1093/schbul/sbr026.
5
Imaging dopamine receptors in humans with [11C]-(+)-PHNO: dissection of D3 signal and anatomy.
Neuroimage. 2011 Jan 1;54(1):264-77. doi: 10.1016/j.neuroimage.2010.06.044. Epub 2010 Jun 30.
6
Blockade of [11C](+)-PHNO binding in human subjects by the dopamine D3 receptor antagonist ABT-925.
Int J Neuropsychopharmacol. 2010 Apr;13(3):273-87. doi: 10.1017/S1461145709990642. Epub 2009 Sep 15.
7
Increased antipsychotic sensitivity in elderly patients: evidence and mechanisms.
J Clin Psychiatry. 2009 Mar;70(3):397-405. doi: 10.4088/jcp.08r04171. Epub 2008 Dec 16.
9
Dopamine D2 receptor binding in drug-naïve patients with schizophrenia examined with raclopride-C11 and positron emission tomography.
Psychiatry Res. 2006 Dec 1;148(2-3):165-73. doi: 10.1016/j.pscychresns.2006.05.009. Epub 2006 Nov 13.
10
The correlative triad among aging, dopamine, and cognition: current status and future prospects.
Neurosci Biobehav Rev. 2006;30(6):791-807. doi: 10.1016/j.neubiorev.2006.06.005. Epub 2006 Aug 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验